在缺血性中风中使用神经保护剂:最近随机试验的证据
Moses John Wesley1, Hamesh Gundala Raja2, Muhammad Salman Shahid3
1Internal Medicine, Annai Hospital, Thuraiyur, IND.
Cureus
|August 22, 2025
概括
本综述检查了急性缺血性中风 (AIS) 的神经保护药物与再注血疗法相结合. 其他药物有混合结果,这表明未来的试验的潜力.
科学领域:
- 神经学
- 药理学
- 临床试验
背景情况:
- 急性缺血性中风 (AIS) 的治疗依赖于再注血疗法.
- 正在探索辅助神经保护策略以改善结果.
研究的目的:
- 在成年AIS患者中,系统地审查与再注射治疗一起使用的神经保护疗法的有效性和安全性.
- 分析过去五年内发表的随机对照试验 (RCT).
主要方法:
- 按照PRISMA指南进行系统审查.
- 在四个数据库中搜索英语RCT.
- 分析了10个符合条件的RCT评估各种神经保护剂.
主要成果:
- 在减少心脏病发作大小和改善功能结果方面,诺莫巴克过氧显示出一致的益处.
- 尼利尼提德和埃达拉显示出不同的结果.
- 大多数研究的偏差风险低至中等.
结论:
- 在AIS中,神经保护剂具有作为再注射治疗的辅助剂的潜力.
- 这是一个有前途的干预措施.
- 需要进一步的研究来澄清其他药物的作用.
相关概念视频
Ischemic Stroke l: Introduction
44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
Ischemic Stroke ll: Pathophysiology
54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54


